Profound and sustained response with next-generation ALK inhibitors in patients with relapsed or progressive ALK-positive anaplastic large cell lymphoma with central nervous system involvement.

ABSTRACT:

SUBMITTER: Rigaud C 

PROVIDER: S-EPMC9425319 | biostudies-literature | 2022 Sep

REPOSITORIES: biostudies-literature